All UTUCs included in the present study were muscle-invasive, and the FGFR3 mutation rate in the UTUC group was 14.3%, which is consistent with previous reports on FGFR3 mutations in muscle-invasive UTUC. The gene discussed is FGFR3; the disease is renal pelvis/ureter urothelial carcinoma.